Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
30.07. | Beyond The Numbers: 6 Analysts Discuss Beta Bionics Stock | 2 | Benzinga.com | ||
30.07. | Beta Bionics stock price target raised to $21 by Truist on strong revenue | 2 | Investing.com | ||
29.07. | Beta Bionics GAAP EPS of -$0.39 beats by $0.08, revenue of $23.2M beats by $3.51M | 14 | Seeking Alpha | ||
29.07. | Beta Bionics Q2 2025 presentation: Revenue soars to $23.2M, guidance raised | 1 | Investing.com | ||
29.07. | Beta Bionics, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
29.07. | Beta Bionics, Inc.: Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | 665 | GlobeNewswire (Europe) | IRVINE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
BETA BIONICS Aktie jetzt für 0€ handeln | |||||
02.07. | Beta Bionics, Inc.: Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025 | 2 | GlobeNewswire (USA) | ||
23.06. | BBNX Stock May Gain From Abbott Deal to Advance iLet Integration | 3 | Zacks | ||
23.06. | Beta Bionics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
23.06. | Analysts expect Beta Bionics patch pump launch by 2027 | 5 | MassDevice | ||
19.06. | Beta Bionics to pair iLet automated insulin delivery system with Abbott's dual glucose-ketone sensor | 2 | MassDevice | ||
19.06. | Beta Bionics, Inc.: Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott's Future Dual Glucose-Ketone Sensor | 332 | GlobeNewswire (Europe) | IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its iLet... ► Artikel lesen | |
16.06. | Beta Bionics stock initiated with Buy rating at Truist Securities | 6 | Investing.com | ||
01.06. | Wolfe Research Initiates Coverage of Beta Bionics (BBNX) Stock with Outperform Rating | 2 | Insider Monkey | ||
30.05. | Goldman Sachs stuft Beta Bionics-Aktie mit Neutral-Rating und Kursziel von 16 US-Dollar ein | 5 | Investing.com Deutsch | ||
30.05. | Goldman Sachs sets Beta Bionics stock at Neutral with $16 target | 2 | Investing.com | ||
07.05. | Beta Bionics Q1 2025 slides: raised guidance despite earnings miss | 3 | Investing.com | ||
06.05. | Beta Bionics GAAP EPS of -$0.93 misses by $0.46, revenue of $17.6M beats by $1.45M | 2 | Seeking Alpha | ||
06.05. | Beta Bionics, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
06.05. | Beta Bionics, Inc.: Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025 | 609 | GlobeNewswire (Europe) | IRVINE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
GERRESHEIMER | 35,840 | -16,26 % | Aixtron, Evotec, Gerresheimer, HelloFresh, Redcare Pharmacy, TeamViewer - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,320 | -1,61 % | Siemens Healthineers kooperiert für Robotersystem mit Stryker | DJ Siemens Healthineers kooperiert für Robotersystem mit Stryker
DOW JONES--Siemens Healthineers will ein Robotersystem für die Behandlung von Schlaganfällen und Aneurysmen gemeinsam mit dem US-Medizintechnologieunternehmen... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 27,980 | 0,00 % | BrightSpring Health Soars Post-IPO on Strong Earnings and Upbeat Analyst Targets | ||
FRESENIUS | 46,810 | -0,51 % | DAX vor Fed-Entscheid stabilisiert: Commerzbank, Fresenius, Munich Re, Beiersdorf, Tesla im ... | Am Dienstag gab es am deutschen Aktienmarkt deutliche Gewinnmitnahmen. Der DAX ging am Ende mit einem Minus von 1,8 Prozent bei 23.329,24 Zählern aus dem Handel. Zum Start in den heutigen Mittwoch dürfte... ► Artikel lesen | |
AVEANNA HEALTHCARE | 8,390 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Announces Successful Debt Refinancing | ATLANTA, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. ("Aveanna") (Nasdaq: AVAH) today announced the closing of its refinanced first lien credit facility. The refinanced credit... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 44,130 | +0,64 % | FMC erhöht Beteiligung an Value-Based-Care-Geschäft | DJ FMC erhöht Beteiligung an Value-Based-Care-Geschäft
DOW JONES--Fresenius Medical Care (FMC) hat ihre Beteiligung am operativen Segment Value-Based-Care (VBC) erhöht und treibt damit nach eigenen... ► Artikel lesen | |
ADAPTHEALTH | 8,970 | 0,00 % | AdaptHealth Corp. - 10-Q, Quarterly Report | ||
UNITEDHEALTH | 298,80 | +1,51 % | HeraMED - Der nächste große KI-Durchbruch in der Frauengesundheit? | ||
CARL ZEISS MEDITEC | 45,640 | -0,65 % | CARL ZEISS MEDITEC AG: Hier zündet die nächste Kursrakete! | ||
CLEARPOINT NEURO | 16,200 | +33,22 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners | SOLANA BEACH, CALIFORNIA / ACCESS Newswire / September 4, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation... ► Artikel lesen | |
ONCOLOGY INSTITUTE | 3,480 | 0,00 % | The Oncology Institute erzielt 1,1 Millionen US-Dollar Einsparungen für Medicare durch Onkologie-Modell | ||
CERIBELL | 12,070 | 0,00 % | Former Silk Road Medical CEO joins CeriBell's board | ||
ECKERT & ZIEGLER | 18,050 | +0,33 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler erhält Zulassung für GalliaPharm® in Japan | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Zulassungsgenehmigung/Markteinführung
Eckert & Ziegler erhält Zulassung für GalliaPharm® in Japan
19.09.2025 / 12:00 CET/CEST
Für... ► Artikel lesen | |
PROGYNY | 21,480 | 0,00 % | Progyny, Inc. Announces Second Quarter 2025 Results | Reports Record Revenue of $332.9 Million, Reflecting 9.5% GrowthGenerates $55.5 Million in Quarterly Operating Cash Flow and Record $105.3 Million over the First Half of 2025 Raises Full Year Guidance... ► Artikel lesen | |
TALKSPACE | 2,640 | 0,00 % | Talkspace auf der Canaccord-Konferenz: Strategiewechsel zum Kostenträger-Modell |